INTERNATIONAL PATENT: CERTIS ONCOLOGY SOLUTIONS, INC. FILES APPLICATION FOR "PI3K-ALPHA INHIBITOR AND MTOR INHIBITOR COMBINATIONS FOR CANCER TREATMENT"

GENEVA, Oct. 1 -- CERTIS ONCOLOGY SOLUTIONS, INC. (5626 Oberlin Dr., Suite 110San Diego, California 92121) filed a patent application (PCT/US2025/021014) for "PI3K-ALPHA INHIBITOR AND MTOR INHIBITOR COMBINATIONS FOR CANCER TREATMENT" on Mar 21, 2025. With publication no. WO/2025/199496, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DO, Long Hoang (5626 Oberlin Dr., Suite 110San Diego, California 92121), CHIEN, Yuan Hung (5626 Oberlin Dr., Suite 110San Diego, California 92121), PIPPA, Raffaella (5626 Oberlin Dr., Suite 1...